Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chelsea Kotch

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Journal of Pediatric Hematology/Oncology|June 14, 2023
The Impact of Proactive Gastrostomy Tube Placement on Treatment-related Outcomes in Young Children With High-grade Central Nervous System TumorsChelsea Kotch, Caitlin W Elgarten, Jessica McWhorter, et al.
The Journal of Pediatrics|May 27, 2023
Retrospective Cohort Analysis of the Impact of Puberty on Plexiform Neurofibroma Growth in Patients with Neurofibromatosis Type 1Chelsea Kotch, Eva Dombi, Amish C Shah, et al.
Cancer Genetics|December 31, 2021
Atypical teratoid rhabdoid tumor in a child with neurofibromatosis type 2: A novel dual diagnosisChelsea Kotch, Michael J Fisher, Fumin Lin, et al.
Journal of Neuro-Oncology|October 6, 2023
The impact of changes in gadolinium-enhancement on disease progression in children with neurofibromatosis type 1-associated optic pathway glioma: a retrospective analysisChelsea Kotch, Stephanie J Si, Kavita Desai, et al.
Cancers|May 13, 2023
Vinblastine/Methotrexate for Debilitating and Progressive Plexiform Neurofibroma in Children and Young Adults with Neurofibromatosis Type 1: A Phase 2 StudyChelsea Kotch, Kristina Wagner, J Harris Broad, et al.
Neuro-Oncology|January 12, 2022
Risk factors for treatment-refractory and relapsed optic pathway glioma in children with neurofibromatosis type 1Chelsea Kotch, Robert Avery, Kelly D Getz, et al.
Human Genetics|October 15, 2025
The spectrum of pathogenic NF1 variants in participants enrolling on clinical trials of MEK inhibitors for plexiform neurofibromaChelsea Kotch, Alicia Gomes, Krista S Schatz, et al.
JCO Precision Oncology|May 26, 2021
NTRK Fusions Identified in Pediatric Tumors: The Frequency, Fusion Partners, and Clinical OutcomeXiaonan Zhao, Chelsea Kotch, Elizabeth Fox, et al.
The New England Journal of Medicine|May 13, 2026
Neuroepithelial Tumor with AAV Integration after Intracisternal Magna Vector DeliveryRebecca C Ahrens-Nicklas, Chelsea Kotch, Aoife M Roche, et al.
Neuro-Oncology|May 19, 2026
Tempered Optimism: Advances in the Precision Medicine Era for Pediatric Low-Grade GliomaChelsea Kotch, Sebastien Perreault, Phoebe Power, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Journal of Pediatric Hematology/Oncology|June 14, 2023
The Impact of Proactive Gastrostomy Tube Placement on Treatment-related Outcomes in Young Children With High-grade Central Nervous System TumorsChelsea Kotch, Caitlin W Elgarten, Jessica McWhorter, et al.
The Journal of Pediatrics|May 27, 2023
Retrospective Cohort Analysis of the Impact of Puberty on Plexiform Neurofibroma Growth in Patients with Neurofibromatosis Type 1Chelsea Kotch, Eva Dombi, Amish C Shah, et al.
Cancer Genetics|December 31, 2021
Atypical teratoid rhabdoid tumor in a child with neurofibromatosis type 2: A novel dual diagnosisChelsea Kotch, Michael J Fisher, Fumin Lin, et al.
Journal of Neuro-Oncology|October 6, 2023
The impact of changes in gadolinium-enhancement on disease progression in children with neurofibromatosis type 1-associated optic pathway glioma: a retrospective analysisChelsea Kotch, Stephanie J Si, Kavita Desai, et al.
Cancers|May 13, 2023
Vinblastine/Methotrexate for Debilitating and Progressive Plexiform Neurofibroma in Children and Young Adults with Neurofibromatosis Type 1: A Phase 2 StudyChelsea Kotch, Kristina Wagner, J Harris Broad, et al.
Neuro-Oncology|January 12, 2022
Risk factors for treatment-refractory and relapsed optic pathway glioma in children with neurofibromatosis type 1Chelsea Kotch, Robert Avery, Kelly D Getz, et al.
Human Genetics|October 15, 2025
The spectrum of pathogenic NF1 variants in participants enrolling on clinical trials of MEK inhibitors for plexiform neurofibromaChelsea Kotch, Alicia Gomes, Krista S Schatz, et al.
JCO Precision Oncology|May 26, 2021
NTRK Fusions Identified in Pediatric Tumors: The Frequency, Fusion Partners, and Clinical OutcomeXiaonan Zhao, Chelsea Kotch, Elizabeth Fox, et al.
The New England Journal of Medicine|May 13, 2026
Neuroepithelial Tumor with AAV Integration after Intracisternal Magna Vector DeliveryRebecca C Ahrens-Nicklas, Chelsea Kotch, Aoife M Roche, et al.
Neuro-Oncology|May 19, 2026
Tempered Optimism: Advances in the Precision Medicine Era for Pediatric Low-Grade GliomaChelsea Kotch, Sebastien Perreault, Phoebe Power, et al.
Pageof 2